Home
Vir Biotechnology VIR paid Forbes-Tate $50K for lobbying in Q2 2026 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $50,000
- Quarter
- Q2 2026
- Client
- Vir Biotechnology
- Reported
- 26/07/20
Up 0.0% from last quarter
What else happened in Vir Biotechnology around then
Filed or reported within 30 days of the trade day · 05/31~07/30Vir Biotechnology's other lobbying reports
- Vir Biotechnology
LobbyingVir Biotechnology
LobbyingVir Biotechnology
VIR
$50K
$50K
Reported 04/19
for Q1
- Vir Biotechnology
LobbyingVir Biotechnology
LobbyingVir Biotechnology
VIR
$50K
$50K
Reported 01/17
for Q4 2025
- Vir Biotechnology
LobbyingVir Biotechnology
LobbyingVir Biotechnology
VIR
$50K
$50K
Reported 25/10/18
for Q3 2025
- Vir Biotechnology
LobbyingVir Biotechnology
LobbyingVir Biotechnology
VIR
$50K
$50K
Reported 25/07/18
for Q2 2025
- Vir Biotechnology
LobbyingVir Biotechnology
LobbyingVir Biotechnology
VIR
$50K
$50K
Reported 25/04/16
for Q1 2025